Cytodyn Inc (CYDY)

[Learning53]

BBNCT,

Saw your note and am updating the bibliography to bring in current items.

Also, because it's getting sort of lengthy (20 pages), I've included a table of topics (that shows the order) on the first page to aid you in locating pertinent data.

*****

Meeting with Clyburn, cool...How soon do you need it?


I just looked through the "Open Secrets" 2020, to assess where the bulk of his campaign contributions came from.


It's a little confusing because on the Main List, while BP lavishes heavy duty funds on almost every senator - he appears to get nothing.

https://www.opensecrets.org/industries/summary.php?ind=H04&cycle=2020&recipdetail=S&mem=Y


Yet, digging deeper, he DOES get Pharma money from PACs and Campaign contributions ($ 214,073), but he is far from being the big winner in this category. And that's from the $ 4.8 million he raised in 2020.

Interestingly, he gets bigger money from lawyers and Insurance.

https://www.opensecrets.org/members-of-congress/james-e-clyburn/summary?cid=N00002408&cycle=2020&type=C

Suggestion: Insurance companies can't be too happy with the expenses their getting from the pandemic.

"Length of stay" is probably a big issue and expense - especially when it comes to ICUs and expensive (intubation, etc.) services. Decreasing length of stay (leronlimab) by 5.5 days - I would think is a winning issue.


Leronlimab's relative ease of administration (subc injection vs expensive infusions) might be worth a few brownie points.


One of the big things that the insurance industry (I would think) is getting hit with, is the plight of the Long Haulers. The expensive treatments, disability income, and lengthy duration (without current effective cure(s) has to be rocking their industry's bottom line). It's too bad that the long hauler results aren't yet available - that would make a home run for the insurers. (Check this out with Misiu - It appears that the bulk of people receiving leronlimab - especially four shots - do not manifest long haulers symptoms. Also the results of HIV people receiving leronlimab - I think Misiu mentioned that they've not contracted Covid or Long Haulers')

Pharma's quest to move toward their "expensive" (questionable - i.e. remdesivir) remedies, rather than other inexpensive treatments, some of which have demonstrated efficacy* - ivermectin, hydroxychloroquine, etc. (in the bibliography), would interest his insurance backers. And the efforts of the FDA to keep competing, effective solutions (leronlimab) out of reach, which would save money, is another issue.

The pharmafolk are lush with money
(spent over $ 300 million in 2020 to "influence the playing field.) https://www.opensecrets.org/federal-lobbying/industries/summary?cycle=2020&id=H04

- especially since the vaccinations are a periodic cash cow going far into the foreseeable future. I'm sure Clyburn's Lawyer supporters would positively salivate at "milking those cows." As they're shown to be cupable, by holding inexpensive and/or effective (leronlimab) remedies at bay, while 600,000 + people die, will provoke some interest.

BBNCT - Looks like you're in the catbird seat, I think you'll have Sen Clyburn broadly smiling as his insurance and lawyer supporters do high-fives (LOL) go get them!

*It appears some of the trials set up to try out the cheaper alternative treatments, were done in a way set up to fail. I believe I've included that information in the bib.

As an aside...Look at how leronlimab is being shunted to only the most critical cases (and the largest chance of failure), instead of being used at earlier stages....Hmmm. Yep..(LOL) talk to misiu... hell, bring her along...